Latest Health News

Page 10 of 271
CSL has appointed ViiV Healthcare CEO Deborah Waterhouse to lead the biopharmaceutical group from 1 February 2027. Her arrival comes with a substantial UK-pound-denominated remuneration package and a mandate to renew the pipeline while simplifying operations.
Ada Torres
Ada Torres
21 Oct 2026
Pro Medicus has secured a seven-year, A$43 million contract with New Jersey healthcare provider Virtua Health, expanding its cloud-based Visage 7 platform across five hospitals. The transaction-based agreement includes cardiology imaging and offers potential upside beyond the disclosed contract value, although the timing of revenue remains unspecified.
Victor Sage
Victor Sage
21 Oct 2026
Percheron Therapeutics has secured a funded path towards a Vanderbilt Health-led HMBD-002 trial in high-risk AML and MDS, while ending September with $4.875 million in cash. The biotechnology company also installed a new chief executive and began a preclinical combination study with Invion.
Ada Torres
Ada Torres
20 Oct 2026
Freelancer returned to operating profit in 3Q26 after cutting operating expenses 11%, but its core marketplace remained under pressure. Record activity at Loadshift and stronger Escrow.com GMV provided the brighter spots while management works to restore demand at Freelancer.
Sophie Babbage
Sophie Babbage
20 Oct 2026
Ramsay Health Care’s proposed separation of its 52.79% Ramsay Santé stake has reached a key regulatory milestone, with ASIC registering the Demerger Booklet. Shareholders will vote on the transaction on 24 November, but approval remains only one step in a process that could create two separately traded healthcare exposures.
Ada Torres
Ada Torres
19 Oct 2026
Algorae has secured exclusive Australian commercial rights across eight Umedica-branded molecules while separately advancing a Umedica-supplied product towards regulatory approval. The broader arrangement remains partly non-binding, with financial terms undisclosed and TGA approval still pending.
Victor Sage
Victor Sage
19 Oct 2026
Pro Medicus has signed a seven-year, A$24 million contract with Billings Clinic - Logan Health for a cloud-based deployment of its Visage 7 imaging platform. The transaction-based structure offers potential additional upside, although the announcement does not quantify future volumes or revenue timing.
Victor Sage
Victor Sage
19 Oct 2026
McPherson’s chief executive and managing director Brett Charlton will step down after more than three years at the helm, with the board beginning an immediate search for his successor. Charlton will remain in the role during a six-month notice period, subject to arrangements agreed with the board.
Victor Sage
Victor Sage
19 Oct 2026
Ramsay Health Care has cleared the first legal step towards distributing its 52.79% stake in Ramsay Générale de Santé to shareholders. The proposed demerger now goes to consecutive shareholder meetings on 24 November, backed by the board and Deloitte’s independent expert.
Ada Torres
Ada Torres
16 Oct 2026
Gulf Stream Energy has identified oil in two separate sandstone zones at its Zydeco project in Louisiana, although the result is based solely on wireline logs and has not yet been flow-tested. The well also retains access to the undrilled Upper Tweedle gas and condensate target.
Victor Sage
Victor Sage
16 Oct 2026
Mayne Pharma has settled its final US Paragraph IV patent dispute over IMVEXXY with Teva, setting a potential generic entry date of 2 September 2032. The agreement removes ongoing litigation without an upfront payment, while leaving court approval and earlier-entry provisions to resolve.
Victor Sage
Victor Sage
16 Oct 2026
Vitura Health grew FY2026 revenue 6% to $131.2 million, but a sharp margin squeeze pushed the ASX-listed digital health company into a $4.4 million statutory loss. With ANZ debt classified as current and a potential $6 million FY2027 revenue hit from changed Bupa referrals, the promised turnaround faces a demanding test.
Ada Torres
Ada Torres
16 Oct 2026

Browse the archive

Full archive